These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 33722668)
1. Tpl2 kinase regulates inflammation but not tumorigenesis in mice. Wu KC; Cain G; Corpuz J; Xu D; Ljumanovic N; Zarrin AA Toxicol Appl Pharmacol; 2021 May; 418():115494. PubMed ID: 33722668 [TBL] [Abstract][Full Text] [Related]
2. Tumor progression locus 2 (TPL2) regulates obesity-associated inflammation and insulin resistance. Perfield JW; Lee Y; Shulman GI; Samuel VT; Jurczak MJ; Chang E; Xie C; Tsichlis PN; Obin MS; Greenberg AS Diabetes; 2011 Apr; 60(4):1168-76. PubMed ID: 21346175 [TBL] [Abstract][Full Text] [Related]
3. The kinase TPL2 activates ERK and p38 signaling to promote neutrophilic inflammation. Senger K; Pham VC; Varfolomeev E; Hackney JA; Corzo CA; Collier J; Lau VWC; Huang Z; Hamidzhadeh K; Caplazi P; Peng I; Setiadi AF; Francis R; Paler-Martinez A; Kwon YC; Ramirez-Carrozzi V; Sun Y; Grigg PW; Roose-Girma M; Jeet S; Barck KH; Pham A; Ota N; Ha C; Stinson J; Guillory J; Tam L; Modrusan Z; Emson C; McKenzie BS; Townsend MJ; Carano RAD; Warming S; Vucic D; DeVoss J; Lee WP; Lill JR; Zarrin AA Sci Signal; 2017 Apr; 10(475):. PubMed ID: 28420753 [TBL] [Abstract][Full Text] [Related]
4. Sterile inflammation in acetaminophen-induced liver injury is mediated by Cot/tpl2. Sanz-Garcia C; Ferrer-Mayorga G; González-Rodríguez Á; Valverde AM; Martín-Duce A; Velasco-Martín JP; Regadera J; Fernández M; Alemany S J Biol Chem; 2013 May; 288(21):15342-51. PubMed ID: 23572518 [TBL] [Abstract][Full Text] [Related]
5. Tumor progression locus 2 (TPL2) in tumor-promoting Inflammation, Tumorigenesis and Tumor Immunity. Njunge LW; Estania AP; Guo Y; Liu W; Yang L Theranostics; 2020; 10(18):8343-8364. PubMed ID: 32724474 [TBL] [Abstract][Full Text] [Related]
6. Tumor Progression Locus 2 in Hepatocytes Potentiates Both Liver and Systemic Metabolic Disorders in Mice. Gong J; Fang C; Zhang P; Wang PX; Qiu Y; Shen LJ; Zhang L; Zhu XY; Tian S; Li F; Wang Z; Huang Z; Wang A; Zhang XD; She ZG Hepatology; 2019 Feb; 69(2):524-544. PubMed ID: 29381809 [TBL] [Abstract][Full Text] [Related]
7. Tumor progression locus 2 ablation suppressed hepatocellular carcinoma development by inhibiting hepatic inflammation and steatosis in mice. Li X; Liu C; Ip BC; Hu KQ; Smith DE; Greenberg AS; Wang XD J Exp Clin Cancer Res; 2015 Nov; 34():138. PubMed ID: 26560698 [TBL] [Abstract][Full Text] [Related]
8. Tumor progression locus 2 (Map3k8) is critical for host defense against Listeria monocytogenes and IL-1 beta production. Mielke LA; Elkins KL; Wei L; Starr R; Tsichlis PN; O'Shea JJ; Watford WT J Immunol; 2009 Dec; 183(12):7984-93. PubMed ID: 19933865 [TBL] [Abstract][Full Text] [Related]
9. TPL2 Is a Key Regulator of Intestinal Inflammation in Clostridium difficile Infection. Wang Y; Wang S; Kelly CP; Feng H; Greenberg A; Sun X Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29844241 [TBL] [Abstract][Full Text] [Related]
11. Tumor progression locus 2/Cot is required for activation of extracellular regulated kinase in liver injury and toll-like receptor-induced TIMP-1 gene transcription in hepatic stellate cells in mice. Perugorria MJ; Murphy LB; Fullard N; Chakraborty JB; Vyrla D; Wilson CL; Oakley F; Mann J; Mann DA Hepatology; 2013 Mar; 57(3):1238-49. PubMed ID: 23080298 [TBL] [Abstract][Full Text] [Related]
12. Tpl2 ablation promotes intestinal inflammation and tumorigenesis in Apcmin mice by inhibiting IL-10 secretion and regulatory T-cell generation. Serebrennikova OB; Tsatsanis C; Mao C; Gounaris E; Ren W; Siracusa LD; Eliopoulos AG; Khazaie K; Tsichlis PN Proc Natl Acad Sci U S A; 2012 May; 109(18):E1082-91. PubMed ID: 22451924 [TBL] [Abstract][Full Text] [Related]
13. Tumor progression locus 2 (Tpl2) deficiency does not protect against obesity-induced metabolic disease. Lancaster GI; Kowalski GM; Estevez E; Kraakman MJ; Grigoriadis G; Febbraio MA; Gerondakis S; Banerjee A PLoS One; 2012; 7(6):e39100. PubMed ID: 22701749 [TBL] [Abstract][Full Text] [Related]
14. Loss of tumor progression locus 2 (tpl2) enhances tumorigenesis and inflammation in two-stage skin carcinogenesis. Decicco-Skinner KL; Trovato EL; Simmons JK; Lepage PK; Wiest JS Oncogene; 2011 Jan; 30(4):389-97. PubMed ID: 20935675 [TBL] [Abstract][Full Text] [Related]
16. The Tpl2 Kinase Regulates the COX-2/Prostaglandin E2 Axis in Adipocytes in Inflammatory Conditions. Berthou F; Ceppo F; Dumas K; Massa F; Vergoni B; Alemany S; Cormont M; Tanti JF Mol Endocrinol; 2015 Jul; 29(7):1025-36. PubMed ID: 26020725 [TBL] [Abstract][Full Text] [Related]
17. Tpl2 kinase is upregulated in adipose tissue in obesity and may mediate interleukin-1beta and tumor necrosis factor-{alpha} effects on extracellular signal-regulated kinase activation and lipolysis. Jager J; Grémeaux T; Gonzalez T; Bonnafous S; Debard C; Laville M; Vidal H; Tran A; Gual P; Le Marchand-Brustel Y; Cormont M; Tanti JF Diabetes; 2010 Jan; 59(1):61-70. PubMed ID: 19808894 [TBL] [Abstract][Full Text] [Related]
18. Tpl2 Ablation Leads to Hypercytokinemia and Excessive Cellular Infiltration to the Lungs During Late Stages of Influenza Infection. Latha K; Jamison KF; Watford WT Front Immunol; 2021; 12():738490. PubMed ID: 34691044 [TBL] [Abstract][Full Text] [Related]
19. Tpl2 Promotes Innate Cell Recruitment and Effector T Cell Differentiation To Limit Citrobacter rodentium Burden and Dissemination. Acuff NV; Li X; Latha K; Nagy T; Watford WT Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28760932 [TBL] [Abstract][Full Text] [Related]